ASD |
antiseizure drug |
MES test |
maximal electroshock seizure test |
6 Hz test |
6 Hertz test |
scPTZ test |
subcutaneous pentylenetetrazole test |
ivPTZ test |
intravenous pentylenetetrazole test |
ADME-Tox |
Absorption Distribution Metabolism Elimination and Toxicology |
PILO |
pilocarpine |
PILO-induced SE |
pilocarpine induced status epilepticus |
DCC |
(N,N′-dicyclohexylcarbodiimide) |
TFA |
trifluoroacetic acid |
HMDS |
hexamethyldisilazane |
MW |
molecular weight |
Log P |
lipholicity values |
HBD |
hydrogen bond donors |
HBA |
hydrogen bond acceptors |
NBR |
number of rotatable bonds |
TPSA |
topological polar surface area |
LIPO |
lipophilicity |
POLAR |
polarity |
INSOLU |
solubility |
FLEX |
flexibility |
INSATU |
saturation of the molecule |
CNS |
central nervous system |
MPO |
multiparameter optimization |
GI |
gastrointestinal |
HIA |
human intestinal absorption |
BBB |
blood-brain barrier |
PGP+/− |
poliglicoprotein |
ED50 |
effective dose |
TD50 |
Toxicity dose |
SD |
Standard Deviation |
TI |
Therapeutic Index |
VPA |
valproic acid |
i.p. |
intraperitoneal injection |
GABAA |
γ-aminobutyric acid A |
AMPA |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
NMDA |
N-methyl-D-aspartic acid |
hERG |
human ether-à-go-go-related gene |
TRPV1 |
Transient receptor potential vanilloid 1 |
VR1 |
Vanilloid type 1 receptor |
5-HT1A |
serotonin 1A |
GAT-1 |
GABA transporter 1 |
SV2A |
synaptic Vesicle Glycoprotein 2A |
PAMPA |
parallel artificial membrane permeability |
HLMs |
Human liver microsomes |
CYP3A4 |
Cytochrome P450 3A4 |
CYP2D6 |
Cytochrome P450 2D6 |
HepG2 |
Hepatoblastoma cell line |
SH-SY5Y |
Human Neuroblastoma cell line |